The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access

Covid Pneumonia in a Female with Metabolic Syndrome – A Case Report


Affiliations
1 Senior Consultant Physician, Mukherjee Multispecialty Hospital, Siliguri, West Bengal, India, India
2 Assistant Professor, North Bengal Medical College and Hospital, Siliguri, West Bengal, India, India
 

   Subscribe/Renew Journal


Evidence across the globe indicates that among patients with confirmed SARS-CoV-2 infection, the outcomes were severe in those with diabetes, obesity, and hypertension with a high incidence of mortality regardless of age. We came across a 43-year-old obese female with type 2 diabetes and hypertension diagnosed with SARS-CoV2 infection. She presented with fever and cough for the previous 3-5 days and subsequently developed breathlessness. Laboratory investigations and radiological findings confirmed the diagnosis of SARS-CoV-2 infection. Our patient had dyspnea and higher CRP, NLR, and LDH than these threshold values with a CTSS of 17 and SpO2 <71%. Moreover, the patient was previously diagnosed with metabolic syndrome. Considering the clinical status, she was hospitalized and managed as per COVID-19 protocol. Even though
at high-risk, the patient recovered well due to the efficient team-work and the holistic approach at our hospital.


Keywords

Metabolic syndrome, SARS-CoV-2 infection, holistic approach
Subscription Login to verify subscription
User
Notifications
Font Size


  • Li C, Islam N, Gutierrez JP, Lacey B, Moolenaar RL, Richter P. Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis. BMJ Open. 2021 Nov 26;11(11):e051711. doi: 10.1136/ bmjopen-2021-051711.

  • Batista DV, Vieira CAFA, Costa TA, Lima EG. COVID-19associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. Diabetol Int. 2020;12(3):313-316. Published 2020 Oct 28. doi:10.1007/ s13340-020-00473-3

  • Clark CE, McDonagh STJ, McManus RJ. et al. COVID-19, and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society.J Hum Hypertens.2021;35:304–307. https://doi.org/10.1038/ s41371-020-00451-x

  • Gentilotti E, Savoldi A, Compri M. et al. Assessment of COVID-19 progression on day 5 from symptoms onset.BMC Infect Dis.2021;21:883. https://doi.org/10.1186/s12879021-06596-5

  • Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring).2020;28(7):1195–9.

  • Mohammad S, Aziz R, Al Mahri S, et al. Obesity and COVID-19: what makes obese host so vulnerable?. Immun Ageing.2021;18:1. https://doi.org/10.1186/s12979-020-00212-x

  • Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA Jr, Liang L. Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of populationbased cohort data. Metabolism. 2020 Nov;112:154345. doi: 10.1016/j.metabol.2020.154345. PMID: 32835759; PMCID: PMC7442576.

  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi:10.1056/NEJMoa2002032.

  • Zhang J, Hao Y,Ou W, et al. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med.2020;18:406. https://doi. org/10.1186/s12967-020-02571-x

  • Cure E, Cure MC. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes MetabSyndr. 2020;14(4):405-406.

  • Bouter P. et al. Effect of epidemic influenza on ketoacidosis,pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in the Netherlands, Diabetes Research and Clinical Practice 1991;12:61-68.

  • CDC. If you have diabetes, a flu shot could save your life. [Internet]. 2007 [2 pages]. Available from: http://www.cdc.gov/diabetes/projects/pdfs/eng-brochure.pdf.

  • National Coalition for Adult Immunization round table panelists. A call to action: Improving influenza and pneumococcal immunization rates among high-risk adults (May 1998) [Internet]. 2004. Available from: http://www.nfid.org/ncai/ publications/roundtable.

  • KyareMH, RoseJrCE, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005 Aug 1;192(3):377-386.doi:10.1086/431521.


Abstract Views: 176

PDF Views: 117




  • Covid Pneumonia in a Female with Metabolic Syndrome – A Case Report

Abstract Views: 176  |  PDF Views: 117

Authors

Sirshendu Pal
Senior Consultant Physician, Mukherjee Multispecialty Hospital, Siliguri, West Bengal, India, India
Rupsha Dutta Pal
Assistant Professor, North Bengal Medical College and Hospital, Siliguri, West Bengal, India, India

Abstract


Evidence across the globe indicates that among patients with confirmed SARS-CoV-2 infection, the outcomes were severe in those with diabetes, obesity, and hypertension with a high incidence of mortality regardless of age. We came across a 43-year-old obese female with type 2 diabetes and hypertension diagnosed with SARS-CoV2 infection. She presented with fever and cough for the previous 3-5 days and subsequently developed breathlessness. Laboratory investigations and radiological findings confirmed the diagnosis of SARS-CoV-2 infection. Our patient had dyspnea and higher CRP, NLR, and LDH than these threshold values with a CTSS of 17 and SpO2 <71%. Moreover, the patient was previously diagnosed with metabolic syndrome. Considering the clinical status, she was hospitalized and managed as per COVID-19 protocol. Even though
at high-risk, the patient recovered well due to the efficient team-work and the holistic approach at our hospital.


Keywords


Metabolic syndrome, SARS-CoV-2 infection, holistic approach

References